Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11660308 Pharmaceutical composition comprising dapagliflozin

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 31 May, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 31 May, 2023
Edits made to:
Infobox (+34 properties)
Article (+432 characters)
‌

 US Patent 11660308 Pharmaceutical composition comprising dapagliflozin

Article

The present invention relates to solid oral pharmaceutical compositions comprising amorphous dapagliflozin. The invention further relates to a process for the preparation of the said pharmaceutical compositions. The said compositions are administered orally for the treatment of diabetes mellitus. The said compositions provide the desired immediate release of dapagliflozin and were found to be stable under accelerated conditions.

Infobox
Is a
Patent
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
116603080
Date of Patent
May 30, 2023
0
Patent Application Number
173029010
Date Filed
May 14, 2021
0
Patent Citations
‌
US Patent 7375213 Methods of producing C-aryl glucoside SGLT2 inhibitors
0
‌
US Patent 7851502 Pharmaceutical formulations containing an SGLT2 inhibitor
0
‌
US Patent 8088743 Methods for treating obesity employing an SGLT2 inhibitor
0
‌
US Patent 8221786 Pharmaceutical formulations containing an SGLT2 inhibitor
0
‌
US Patent 8361972 Pharmaceutical formulations containing an SGLT2 inhibitor
0
‌
US Patent 8501698 Crystal structures of SGLT2 inhibitors and processes for preparing same
0
‌
US Patent 8518895 Method for treating hyponatremia employing an SGLT2 inhibitor and composition containing same
0
‌
US Patent 8535715 Bilayer tablet formulations
0
‌
US Patent 8592371 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
0
‌
US Patent 8603989 Method for treating and preventing kidney stones employing an SGLT2 inhibitor and composition containing same
0
‌
US Patent 8716251 Pharmaceutical formulations containing an SGLT2 inhibitor
0
‌
US Patent 8772328 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
0
‌
US Patent 8791077 Method for treating hyperuricemia employing an SGLT2 inhibitor and composition containing same
0
‌
US Patent 8853385 Combination therapy comprising SGLT inhibitors and DPP4 inhibitors
0
‌
US Patent 8871264 Immediate release tablet formulations
0
‌
US Patent 8952139 Process for the preparation of β-C-aryl glucosides
0
‌
US Patent 8999941 Crystalline and non-crystalline forms of SGLT2 inhibitors
0
‌
US Patent 9278976 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes
0
‌
US Patent 9403790 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
0
‌
US Patent 9550747 Dapagliflozin crystalline form and preparation method thereof
0
‌
US Patent 9834533 Process for preparing SGLT2 inhibitors and intermediates thereof
0
‌
US Patent 11020412 Pharmaceutical composition comprising dapagliflozin
0
Patent Primary Examiner
‌
Yih-Horng Shiao
0
CPC Code
‌
A61K 9/2054
0
‌
A61K 9/2031
0
‌
A61K 9/2018
0
‌
A61K 9/2009
0
‌
A61K 31/70
0

Find more entities like US Patent 11660308 Pharmaceutical composition comprising dapagliflozin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.